AlphaStocks

CTRE vs PEB

CareTrust REIT, Inc. vs Pebblebrook Hotel Trust — Side-by-Side Stock Comparison

CTRE

CareTrust REIT, Inc.

6.1

Consider Buy

$37.12

PEB

Pebblebrook Hotel Trust

7.2

Consider Buy

$12.66

CTRE vs PEB: Which is the Better Investment?

CareTrust REIT, Inc. (CTRE) scores 6.1/10 while Pebblebrook Hotel Trust (PEB) scores 7.2/10 on AlphaStocks' composite model. Pebblebrook Hotel Trust has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricCTREPEB
Scores & Fundamentals
Composite Score6.1/107.2/10
RatingConsider BuyConsider Buy
Price$37.12$12.66
P/E Ratio23.6
ROE8.0%-2.6%
Market Cap$8B$2B
Fair Value$25.70
Dividend Yield3.4%
Sector Rank#12 of 105#2 of 105
Model Verdicts
PiotroskiAttractiveNeutral
BuffettAttractiveStrong
GrahamAttractiveAttractive
LynchAttractiveLimited Data
GreenblattCautionCaution
View full CTREanalysis →View full PEBanalysis →
Compare any two stocks →

CTRE vs PEB: Which Stock Scores Higher?

CareTrust REIT, Inc. (CTRE) and Pebblebrook Hotel Trust (PEB) are among the most compared stocks in the Real Estate sector. PEB currently leads with a composite score of 7.2/10 (Consider Buy) compared to CTRE's 6.1/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer